Skip to content
Search

Latest Stories

Ram Setu: Akshay Kumar starts shooting for the film

Ram Setu: Akshay Kumar starts shooting for the film

By Murtuza Iqbal

A few days ago, the Mahurat of Akshay Kumar starrer Ram Setu took place in Ayodhya, India, and today the actor has kickstarted the shooting of the film.


Akshay took to Instagram to inform his fans about it. He posted a picture from the sets and wrote, “The journey of making one of the most special films for me begins today. #RamSetu shooting begins! Playing an archaeologist in the film. Would love to hear your thoughts on the look? It always matters to me?? @jacquelinef143 @nushrrattbharuccha @abundantiaent @lyca_productions @primevideoin @ivikramix @shikhaarif.sharma #AbhishekSharma #DrChandraprakashDwivedi #CapeOfGoodFilms @harjeetsphotography.”

Ram Setu also stars Jacqueline Fernandez and Nushrratt Bharuccha. The movie is produced by Akshay Kumar, Lyca Productions, Abundantia Entertainment and Amazon Prime Video. With Ram Setu, Amazon Prime Video forays into film production in India.

Vijay Subramanium, Director and Head, Content, Amazon Prime Video India had earlier said in a statement, “At Amazon Prime Video, every decision we take is from a customer-first perspective. Stories that are entrenched in Indian soil have often found an audience not only in India but across the world, and we are delighted to further take a step into co-producing by collaborating with a film that highlights our Indian heritage. Our collaboration with Vikram Malhotra and Abundantia Entertainment as well as with Akshay Kumar till date has been unique and highly successful; and with this step, we move into the direction of further deepening and strengthening our association. With an exemplary cast and a story that is unique yet steeped in history, we look forward to continuing to entertain our customers the world over.”

Ram Setu is being directed by Abhishek Sharma.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less